Intracellular modulation of NMDA receptor function by antipsychotic drugs
about
Glutamatergic modulation of hyperactivity in mice lacking the dopamine transporterNeurotensin-deficient mice show altered responses to antipsychotic drugsPosttranscriptional regulation of BK channel splice variant stability by miR-9 underlies neuroadaptation to alcoholThe suppression of brain cold-stable microtubules in mice induces synaptic defects associated with neuroleptic-sensitive behavioral disordersAntipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotectionMolecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment.Time-dependent changes in gene expression profiles of midbrain dopamine neurons following haloperidol administration.Hyperdopaminergic tone erodes prefrontal long-term potential via a D2 receptor-operated protein phosphatase gateExpression of the NR2B-NMDA receptor trafficking complex in prefrontal cortex from a group of elderly patients with schizophrenia.Existing and novel biological therapeutics in suicide prevention.Maladaptive striatal plasticity in L-DOPA-induced dyskinesia.Dopamine D2-like antagonists induce chromatin remodeling in striatal neurons through cyclic AMP-protein kinase A and NMDA receptor signaling.L-type Ca2+ channel blockers promote Ca2+ accumulation when dopamine receptors are activated in striatal neuronsDopamine D1 receptors mediate CREB phosphorylation via phosphorylation of the NMDA receptor at Ser897-NR1.Antipsychotic drugs and neuroplasticity: insights into the treatment and neurobiology of schizophrenia.Dopamine-dependent increases in phosphorylation of cAMP response element binding protein (CREB) during precipitated morphine withdrawal in primary cultures of rat striatum.Glutamatergic dysbalance and oxidative stress in in vivo and in vitro models of psychosis based on chronic NMDA receptor antagonism.Effect of paliperidone and risperidone on extracellular glutamate in the prefrontal cortex of rats exposed to prenatal immune activation or MK-801.Behavioural and molecular endophenotypes in psychotic disorders reveal heritable abnormalities in glutamatergic neurotransmission.Abnormal activity of the MAPK- and cAMP-associated signaling pathways in frontal cortical areas in postmortem brain in schizophrenia.The relationship between duration of initial alcohol exposure and persistence of molecular tolerance is markedly nonlinear.Developmental regulation of the NMDA receptor subunits, NR3A and NR1, in human prefrontal cortex.Cocaine effects on dopamine and NMDA receptors interactions in the striatum of Fischer rats.Dopaminergic synapses in the caudate of subjects with schizophrenia: relationship to treatment responseClozapine functions through the prefrontal cortex serotonin 1A receptor to heighten neuronal activity via calmodulin kinase II-NMDA receptor interactions.Metabotropic glutamate receptors: potential drug targets for psychiatric disorders.Antipsychotic drugs elevate mRNA levels of presynaptic proteins in the frontal cortex of the rat.Striatal proenkephalin gene induction: coordinated regulation by cyclic AMP and calcium pathways.Current Concepts and Treatments of Schizophrenia
P2860
Q24555193-8EFD4B02-79F4-413D-9CB1-93407E74AC39Q24632801-ADB04ABC-443E-47AE-A935-B15C970561EFQ24646484-9BC397DF-15F5-4742-B6B7-57961DA534B9Q24682931-D16C3BB0-C297-4410-B85D-1118C073AC20Q30386608-F0FF3E2F-304D-4805-A5B8-4F58A38C6E1FQ30428213-5AF8C043-9F61-4C88-B8A4-AA18FD302F77Q30981438-CA155014-5E07-4CB6-853B-9FC4F75339FBQ33638853-83F93348-6B15-41EE-8AE0-B97675AA0B77Q33846961-8E03CDC6-EB56-4494-8F58-74A5244E6DE6Q34085866-34624953-EEF8-419A-8C49-D2A8712ED1A6Q34094008-3CAC80CB-34AA-430B-9C26-50934A1DB679Q34372135-F29E6CED-27AE-4E91-B880-1A634C2BB47BQ34372233-D016F963-80C7-4178-A2BB-2E3C1051539CQ34372253-A12B6DD2-E625-490D-B9DF-198562323880Q34383654-CDA15E10-E61D-4DF4-AC3A-62EC4ED0F5CCQ34383670-E68F3BBE-78BD-408C-AFD1-7D43C255C211Q34837403-59F43C35-50E4-4E2F-92F2-94284B4CF311Q35129718-601D0010-8751-40BB-820E-B9B53F99ECC6Q35598785-01EFFD79-3194-4CF7-9191-BC91764D1C01Q35760215-F9D5A55E-DBAD-45C4-BAE4-C2F50D74E3F6Q37135618-B61C3C5C-0C80-4219-9C98-04C5F41A5D8AQ37322477-22D2D468-65C7-4C7B-8609-CF4082437700Q37394262-94356A97-FA26-41E0-BE0B-3AAC19FC173AQ37405204-7B684ADD-6360-49D5-BC57-E402260FE23CQ40226041-96F99356-321D-4354-A5C3-F48103A02775Q41157725-331037E6-5848-4DEB-A8BC-E7DCD6E32342Q42539139-F2C618AB-29D1-4E1E-A318-CAA89AEDE9C5Q42955171-6DCD509B-70D9-4E5C-BABB-000443DCBB86Q58693044-C5738DCF-4238-477D-8737-726B1301BE70
P2860
Intracellular modulation of NMDA receptor function by antipsychotic drugs
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Intracellular modulation of NMDA receptor function by antipsychotic drugs
@ast
Intracellular modulation of NMDA receptor function by antipsychotic drugs
@en
Intracellular modulation of NMDA receptor function by antipsychotic drugs
@nl
type
label
Intracellular modulation of NMDA receptor function by antipsychotic drugs
@ast
Intracellular modulation of NMDA receptor function by antipsychotic drugs
@en
Intracellular modulation of NMDA receptor function by antipsychotic drugs
@nl
prefLabel
Intracellular modulation of NMDA receptor function by antipsychotic drugs
@ast
Intracellular modulation of NMDA receptor function by antipsychotic drugs
@en
Intracellular modulation of NMDA receptor function by antipsychotic drugs
@nl
P2093
P2860
P1476
Intracellular modulation of NMDA receptor function by antipsychotic drugs
@en
P2093
A Rajadhyaksha
R L Huganir
R R Carlson
P2860
P304
P356
10.1523/JNEUROSCI.20-11-04011.2000
P407
P577
2000-06-01T00:00:00Z